Decision Counseling and Follow-up for Shield+ Patients
ConditionColo-rectal Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45-75
SponsorGuardant Health, Inc.
About this trial
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Eligibility criteria
Qualifiers
Participant is 45-75 years old at the time of ShieldTM test order.
Participant has a valid Shield(+) test result.
Participant is willing and able to complete the informed consent process
Participant is able to complete the informed consent process and decision counseling session in English
Disqualifiers
Participant is already enrolled in another Guardant Health, Inc. clinical study or has received a positive MCD result for a cancer type other than CRC.
Trial design
Treatments tested in this trial
- Decision Counseling Session
Treatment groups
350 Participants
are divided into 1 treatment groupSponsors and collaborators
Guardant Health, Inc.
Lead sponsor
Thomas Jefferson University
Collaborator
Source ClinicalTrials.gov